Ticker Scorecard - UBX Basics Company: Unity Biotechnology, Inc. IPO Date: April 30, 2018 Sector: Healthcare Industry: Biotech Market Cap: $32.69M Activated in VL: True Average Daily Range Avg Daily Range: $0.17 | 3.61% Avg Daily Range (30 D): $0.11 | 5.79% Avg Daily Range (90 D): $0.07 | 4.48% Institutional Daily Volume Avg Daily Volume: .11M Avg Daily Volume (30 D): .24M Avg Daily Volume (90 D): .15M Trade Size Avg Trade Size (Sh.): 44 Avg Trade Size (Sh.) (30 D): 209 Avg Trade Size (Sh.) (90 D): 220 Institutional Trades Total Inst.Trades: 85 Avg Inst. Trade: $1.92M Avg Inst. Trade (30 D): $.79M Avg Inst. Trade (90 D): $.79M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.26M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 44.4K     News May 17, 2024 @ 4:00 PM All You Need to Know About UNITY Biotechnology (UB... Source: Zacks Equity Research Apr 17, 2024 @ 12:21 PM Visa To Rally Around 18%? Here Are 10 Top Analyst ... Source: Avi Kapoor Apr 15, 2024 @ 11:00 AM UNITY Biotechnology, Inc. Reports Fourth Quarter a... Source: Unity Biotechnology, Inc. Nov 16, 2023 @ 7:41 PM Unity Biotechnology Upgraded - Analyst Highlights ... Source: Shivani Kumaresan Nov 13, 2023 @ 9:05 PM UNITY Biotechnology, Inc. Reports Third Quarter 20... Source: Unity Biotechnology, Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.38 $-.31 $-.34 Diluted EPS $-.38 $-.31 $-.34 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -6.48M $ -5.28M $ -5.79M Operating Income / Loss $ -6.6M $ -6.98M $ -7.6M Cost of Revenue $ $ $ Net Cash Flow $ 1.31M $ -12.22M $ M PE Ratio     Splits Oct 20, 2022:   10:1